Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Capricor Therapeutics (CAPR) Return on Assets (2016 - 2025)

Historic Return on Assets for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to 0.44%.

  • Capricor Therapeutics' Return on Assets rose 800.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.35% for FY2024, which is 600.0% up from last year.
  • According to the latest figures from Q3 2025, Capricor Therapeutics' Return on Assets is 0.44%, which was up 800.0% from 0.32% recorded in Q2 2025.
  • Capricor Therapeutics' Return on Assets' 5-year high stood at 0.17% during Q2 2022, with a 5-year trough of 0.7% in Q3 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.44% (2021), whereas its average is 0.41%.
  • As far as peak fluctuations go, Capricor Therapeutics' Return on Assets tumbled by -4700bps in 2023, and later surged by 3200bps in 2025.
  • Capricor Therapeutics' Return on Assets (Quarter) stood at 0.49% in 2021, then soared by 45bps to 0.27% in 2022, then tumbled by -72bps to 0.47% in 2023, then surged by 34bps to 0.31% in 2024, then crashed by -44bps to 0.44% in 2025.
  • Its Return on Assets was 0.44% in Q3 2025, compared to 0.32% in Q2 2025 and 0.19% in Q1 2025.